At our center, we offer medical and surgical treatments as well as other therapeutic approaches which are highly effective in easing symptoms.
A number of medical therapies are available and effective in treating the symptoms of most movement disorders. Your team at OSF HealthCare Illinois Neurological Institute will work with you to find a regimen that best fits your needs and lifestyle.
Sinemet is a combination of two common medications used to treat Parkinson’s Disease: Carbidopa and Levodopa.
Levodopa is a substance that is converted into Dopamine in the brain. This is the most widely prescribed treatment for Parkinson’s.
Carbidopa works by preventing the breakdown of levodopa in the bloodstream. This allows more levodopa to enter the brain. By helping more levodopa get into the brain so that less stays in the bloodstream, carbidopa can reduce some of levodopa’s side effects. The most common side effect of levodopa is nausea.
Carbidopa/levodopa (Sinemet) gets absorbed through the gut—mainly the small intestines.
Carbidopa/levodopa often helps with symptoms of Idiopathic Parkinson’s Disease – including slowness, and stiffness. Tremors can be resistant to levodopa.
It is available in different dosages and in short-acting and long-acting formulation.
Things to Know:
Rytary is a combination of two common medications used to treat Parkinson’s Disease: Carbidopa and Levodopa.
This medication is a truly extended release version of carbidopa/levodopa (Sinemet).
Rytary is released from the capsule filled with beads and is absorbed into your body similarly to that of regular carbidopa/levodopa (Sinemet). The Rytary stays in your body for about 4 to 5 hours.
Taking Rytary will avoid the peaks and valleys fluctuations that can be seen with taking immediate release carbidopa/levodopa.
You will start taking Rytary three times a day.
Because of the way Rytary is formulated, the dose of levodopa is higher than what you have received before.
Patients with early Parkinson’s disease experience a significant improvement in their ability to move and perform activities during the day.
Patients with advanced Parkinson’s disease experience significantly less “OFF” time and more “ON” time without troublesome dyskinesia during the day.
Things to know:
Stalevo is a combination of three common medications used to treat Parkinson’s Disease: Carbidopa and Levodopa (which are the active ingredients in Sinemet) and Entacapone (which is the active ingredient in Comtan). Taking Stalevo will allow you to take one medication instead of two separate ones and may also help you to experience fewer signs and symptoms of wearing off.
Levodopa is a substance that is converted into Dopamine in the brain. This is the most widely prescribed treatment for Parkinson’s.
Carbidopa helps prevent levodopa from being broken down in the gut, liver, and other tissues. This allows more levodopa to reach the brain and also helps prevent nausea and vomiting.
Entacapone (Comtan) will enhance the action of Levodopa.
Stalevo is available in 3 separate dosage forms. We may only need this medication on an "as needed basis". Your provider will decide what's best for you.
Things to Know:
Amantadine belongs to a class of medications known antivirals. It is unclear as to how it works, but Amantadine reduces symptoms of fatigue and tremor in some people with early Parkinson’s disease. It can also help with dyskinetic movements. The older you get, the less likely you are to be placed on Amantadine.
Things to Know:
MAO-B inhibitors act by slowing down the breakdown of dopamine in the brain, prolonging the action of dopamine and improving Parkinson’s disease symptoms such as slow movements and rigidity.
Selegiline (Eldepryl) and Rasagiline (Azilect) offer mild symptomatic benefit, primarily in patients with early disease.
In more advanced Parkinson’s disease, it may be used in combination with carbidopa/levodopa (Sinemet).
Things to Know:
Ropinirol (Requip), Primapexole (Mirapex) and Neupro (Rotigotine) are dopamine agonists which work by mimicking the effects of natural dopamine. These medications decrease tremors, stiffness and slow movements.
Dopamine agonists directly stimulate the receptors in nerves in the brain that normally would be stimulated by dopamine. Unlike levodopa, a dopamine agonist is not changed (converted) into dopamine when it enters the body, but it behaves like dopamine.
These medications can be used in early stages of Parkinson’s disease.
They also can be used in combination with Sinemet (carbidopa/levodopa) in late Parkinson’s disease.
Things to Know:
DO NOT STOP AGONISTS SUDDENLY. YOU WILL BE EDUCATED IN HOW TO SLOWLY WEAN OFF OF THIS MEDICATION.
Physical exercise and endurance have repeatedly been shown to improve symptoms and overall quality of life in patients affected by these conditions. Here at the Illinois Neurological Institute, we have physical, occupational, and speech therapists that are specialty-trained in the neurosciences. For example, we offer the and Lee Silverman Voice Technique BIG and LOUD programs which are internationally recognized and especially developed to improve function in patients with Parkinson’s disease.
For some patients, surgery is an option. OSF INI is proud to offer deep brain stimulation (DBS) surgery as an option for our patients and our team is specialty trained in DBS. DBS is an FDA approved surgical treatment for Parkinson’s disease and essential tremor. Worldwide, approximately 100,000 patients have undergone deep brain stimulation surgery. DBS is commonly referred to as a “brain pacemaker” and two small wires are placed deep within the brain to disrupt abnormal signals causing symptoms of disease. A battery is implanted in the chest and the device can be adjusted to improve symptoms over time.
Although DBS is an effective treatment option for some, it is not for every patient. Patients with dementia or atypical syndromes are not typically candidates. The surgery is not a cure for Parkinson’s disease or essential tremors but can help to alleviate symptoms. DBS is a consideration for patients with disabling essential tremors that do not respond to medication or for Parkinson’s patients with severe tremor, medication induced dyskinesia or fluctuations in their response to medication. There are other indications for DBS including cervical and generalized dystonia.
You will work with our team to determine if you are a candidate for surgery. The process typically requires an evaluation by our DBS specialist, our functional neurosurgeon and a neuropsychologist. This is done to ensure you are getting the necessary and best care available. The surgeries are performed at OSF Saint Francis Medical Center in Peoria and include intra-operative brain mapping and testing of the device. Our movement disorders specialists and staff are trained in the management of DBS after surgery is completed.
There is a process before scheduling a DBS procedure:
Risks and complications can be discussed with your provider.
Duopa is a prescription medication mainly used for treatment of motor fluctuations in advanced Parkinson’s disease.
In addition to medical and surgical therapies, OSF INI's Parkinson's Disease and Movement Disorders Center offers treatment with botulinum toxin. Botulinum toxin is an FDA-approved treatment for several conditions including dystonia, blepharospasm, hemifacial spasm, and drooling associated with neurodegenerative disease. Botulinum toxin blocks the neurotransmitter acetylcholine from being released into the space between the muscle/gland and nerve. This temporarily decreases the overactive contraction of the muscles or production of saliva from glands, allowing the patient to improve symptoms. Some patients experiencing pain associated with the dystonia may also experience improvement.
Despite the medication being a toxin, proper infiltration of the muscles at the correct dosages usually provides the desired benefit with minimal to no side effects. Our team uses EMG (electromyography) guidance to better determine ideal placement for the toxin. Your doctor will discuss the potential complications of the treatment before proceeding. Expected side effects during the injections include pain at the injection site, bleeding and sometimes, a small hematoma. Relief typically lasts between 2-3 months and repeated injections are needed to maintain results.